Imprimis Pharmaceuticals Inc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (29)

View All

Latest Posts

About This Stock More About This Stock
Best Sector Of 2018 And Its Hit ETFs & Stocks
Article By: Sweta Killa
Thursday, January 3, 2019 1:45 AM EDT
The healthcare sector has been heating up with merger frenzy that could change the landscape of healthcare business. Investors might want to tap into the space with the top-performing healthcare ETFs and stocks of 2018.
In this article: IHI, PSCH, XHE, XLV, VHT, TNDM, PRQR, CDNA, HEMA, IMMY
Read
Senator Thwarts Allergan's Patent Transfer, Inflaming The Mohawks
Article By: Shock Exchange
Friday, October 6, 2017 5:51 PM EDT
Senator Claire McCaskill drafted a bill to thwart the transfer of AGN's Restasis patents to the Mohawk Tribe. Next steps could be to push for Medicare Part D access for SHPG's Xiidra and prioritize clinical stage drugs from RGRX or ALDX.
In this article: AGN Also: SHPG, RGRX, ALDX, TEVA, IMMY
Read
Allergan Takes Legal Action Against Another Restasis Competitor
Article By: Shock Exchange
Thursday, September 21, 2017 11:15 AM EDT
Allergan has dominated the financial news cycle since it agreed to sell its Restasis patents to St. Regis Mohawks in order to protect them.
In this article: AGN Also: IMMY, MYL, MS, SHPG, PFE, TEVA
Read
Bear Market Biotech Rally Is Tradeable
Article By: Rod Raynovich
Wednesday, December 16, 2015 10:06 AM EDT
We are still almost 18% off July highs and need to catapult out of a downward channel in the sector to confirm a long term secular bull market.
In this article: FBIOX, IBB Also: PRHSX, QQQ, XBI, XLV, IMMY
Read
All Posts

Latest Tweets for $IMMY

No tweets yet!

PARTNER HEADLINES